1. Hook EW, 3rd. Syphilis. Lancet 2017; 389(10078): 1550-7.
2. Radolf JD, Tramont EC, Salazar JC. Syphilis (Treponema pallidum). Principlesand Practice of Infectious Diseases. In: Bennett JE, Dolin R, BlaserMJ,eds.Ninthedition.Philadelphia. 2020 byEl-
sevier.2865-2892.
3. A E Singh , B Romanowski. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev. 1999;12(2):187-209.
4. Zarakolu P. Sifilisin Laboratuvar Tanısında Güncel Gelişmeler.Mikrobiyol Bul. 2023;57(1):141-155.
5. KimberlyA,Workowski KA, Bachmann LH, et al.Sexually Transmitted Infections Treatment Guidelines, 2021.MMWR RecommRep. 2021;70(4):1-187.
6. Barnes I, Thomas MG. Evaluating bacterial pathogen DNA preservation in museum osteological collections. ProcBiolSci. 2006;273:645–653.
7. VonHunnius TE, Yang D, Eng B, et al. Digging deeper into the limits of ancient DNA research on syphilis. JArchaeolSci. 2007;34:2091–2100.
8. PesapaneF,MarcelliS,Nazzaro G. Hieronymi Fracastorii: the Italian scientist who described the “French disease”*
An BrasDermatol. 2015; 90(5): 684–686.
9. Collen EJ, Johar AS, Teixeria JC.et al. The immunogenetic impact of European colonization in the Americas. FrontGenet. 2022;13: 1-12.
10. Tsuboi M, Evans J, Davies EP. et al. Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000-20. Lancet GlobHealth.
2021;9(8):e1110-e1118.
11. https://www.cdc.gov/std/statistics/2022/overview.htm
12. Lee V, Kinghorn G. Syphilis: an update. ClinMed (Lond).2008;8(3):330-3.
13. Hamill MM, Ghanem KG, Tuddenham S. State-of-the-Art Review: Neurosyphilis. ClinInfectDis. 2023;18:ciad437.1-13.
14. Bond SM, BlainMLM . .Diagnosis and Treatment of Secondary Syphilis in Women. J Midwifery Womens Health. 2021;66(3):372-379.
15. Ghanian S, Costa RD, Singer H.et al. Extensive luesmaligna syphilis in an immunocompromised male.I nt J Dermatol. 2022;61(10):e410-e411.
16. Goh BT. Syphilis in adults. Sex Transm Infect. 2005;81: 448-52
17. Forrestel AK, Kovarik CL, Katz KA. Sexually acquired syphilis: Historical aspects, microbiology, epidemiology, and clinical manifestations. J AmAcadDermatol. 2020;82(1):1-14.
18. Chahine LM, Khoriaty RN, Tomford WJ. et al. The changing face of neurosyphilis. Int J Stroke. 2011;6:136–143.
19. HutchinsonCM, HokkEW. Syphilis in adults.Med Clin North Am.1990;74(6):1389-416
20. Jackman JD, Radolf JD. Cardiovascular syphilis. Am J Med 1989;87:425-433
21. Chow EP, Wilson DP, Zhang L. HIV and syphilis co-infection increasing among men who have sex with men in China: a systematic review and meta-analysis. PLoSOne. 2011;6(8): 22768.
22. Weiner MF, Silver JR. Historical review: suspension therapy for the treatment of tabes dorsalis. Eur Neurol. 2014;72(3-4):163-72.
23. Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. JAMA. 2003;290(11):1510-4.
24. KiarieJ,Mishra CK, TemmermanM.et al. Accelerating the dual elimination of mother-to-child transmission of syphilis and HIV: Why now? Int. J. Gynaecol. Obstet. 2015;130 (Suppl. 1), S1–S3
25. Stafford IA, Workowski KA, Bachmann LH. Syphilis Complicating Pregnancy and CongenitalSyphilis. NEngl J Med. 2024;390(3):242-253.
26. Hawkes S, Matin N, Broutet N. et al. Effectiveness of interventions to improve screening for syphilis in pregnancy: A systematic review and meta-analysis. Lancet Infect. Dis. 2011;11:684–691.
27. KimYH, Song JH, Kim CJ. et al. Congenital Syphilis Presenting with Only Nephrotic Syndrome: Reemergence of a Forgotten Disease. J. Korean Med. Sci. 2017;32:1374–1376.
28. Wheeler HL, Agarwal S, Goh BT. Dark ground microscopy and treponemal serological tests in the diagnosis of early syphilis. SexTransm Infect. 2004;80:411–414
29. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev. 1995;8:1–21.
30. JanierM , Unemo M, Dupin N. et al. 2020 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol. 2021;35(3):574-588.
31. T.C. Sağlık Bakanlığı, Türkiye Halk Sağlığı Kurumu, Mikrobiyoloji Referans Laboratuvarları Daire Başkanlığı “Ulusal Mikrobiyoloji Standartları: Bulaşıcı Hastalıklar Laboratuvar Tanı Reh-
beri” Cilt-1. Ankara, Aydoğdu Ofset Matbaacılık,2014;334-350.
32. Tong ML, Lin LR, Liu LL, et al. Analysis of 3 algorithms for syphilis serodiagnosis and implications for clinical management. Clin Infect Dis. 2014;58:1116–1124.
33. Chan P, Colby DJ, Kroon E. et al. Clinical and laboratory impact of concomitant syphilis infection during acute HIV. HIV Med. 2021;22(6):502-511.
34. Soreng K, LevyR, FakileY. Serologic Testing for Syphilis: Benefits and Challenges of a Reverse Algorithm. Clin Microbiol Newsl. 2014;36(24):195-202.
35. Park IU, Tran A, PereiraL,et al. Sensitivity and Specificity of Treponemal-specific Tests for the Diagnosis of Syphilis. Clin Infec tDis. 2020;71(Suppl 1):S13-S20.
36. Bristow CC, Klausner JD, Tran A. Clinical test performance of a rapid point-of-care syphilis treponemal antibody test: a systematic review and meta-analysis. Clin Infect Dis 2020;71(Suppl
1):S52–7.
37. Ratnam S. The laboratory diagnosis of syphilis. Can J Infect Dis Med Microbiol.2005;16(1):45-51.
38. Guidelines for the management of symptomatic sexually transmitted infections. World HealthOrganization 2021.1-216. https://www.who.int/publications/i/item/9789240024168
39. MeredithE,Clement ME, LanceN,et al.Treatment of syphilis: a systematic review. JAMA. 2014;312(18):1905-17.
40. Tseng YT, Chou PY, Tai MH, et al. High Baseline C-Reactive Protein Level Can Predict the Occurrence of the Jarisch-HerxheimerReaction in Patients with Active Syphilis. Infect DrugResist.
2021:14:5121-5129.
41. Butler T. The Jarisch–Herxheimer Reaction After Antibiotic Treatment of Spirochetal Infections: A Review of Recent Casesand Our Understanding of Pathogenesis.Am J Trop Med Hyg. 2017;
96(1): 46–52.
42. Fekade D, Knox K, Hussein K, et al. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med. 1996;335:311–315.
43. Enkhbat E, Korenromp EL, Badrakh. Adult female syphilis prevalence, congenital syphilis case incidence and adverse birth outcomes, Mongolia 2000–2016: Estimatesusing theS pectrum STI
tool .InfectDis Model. 2018;3:13–22.
44. McDonald R, O’Callaghan K, Torrone E et al. VitalSigns: Missed Opportunities for Preventing Congenital Syphilis – United States, 2022.MMWR 2023;72(46):1269-1274.
45. https://www.mevzuat.gov.tr/anasayfa/MevzuatFihristDetayIframe?MevzuatTur=9&MevzuatNo=8580&MevzuatTertip=5